Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

盐酸二氧丙嗪颗粒 - NMPA Drug Approval Details

Approvals/NMPA/Dioxopromethazine Hydrochloride Granules

Approved

化学药品

Dioxopromethazine Hydrochloride Granules

吉林东懿制药有限公司🇨🇳 National Medical Products Administration

Approval Date: Mar 25, 2003
Approval ID: 7zz3xJ8yOhh
Company: 吉林东懿制药有限公司
Type: 化学药品

Approval Details

Approval Id: 7zz3xJ8yOhh
Approval Number: 国药准字H22024606
Generic Name: 盐酸二氧丙嗪颗粒
Generic Name En: Dioxopromethazine Hydrochloride Granules
Drug Type: 化学药品
Strength: 1.5mg
Reg Date: 2003-03-25
Company Name: 吉林东懿制药有限公司
Production Company Address: 四平市铁东区团结路117号
Company Detail Path: /organization/ji-lin-dong-yi-zhi-yao-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Mar 25, 2003

Approval ID

7zz3xJ8yOhh

Type

化学药品

Back to NMPA Approvals